235 related articles for article (PubMed ID: 15870860)
21. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine kinase fusion genes in chronic myeloproliferative diseases.
Cross NC; Reiter A
Leukemia; 2002 Jul; 16(7):1207-12. PubMed ID: 12094244
[TBL] [Abstract][Full Text] [Related]
23. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
[TBL] [Abstract][Full Text] [Related]
24. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ
Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597
[TBL] [Abstract][Full Text] [Related]
25. bcr gene rearrangement analysis in myeloproliferative disorders other than chronic myelogenous leukemia.
Crisan D; Mattson JC; O'Malley BA; Schulz RW; Wilner F
Cancer Detect Prev; 1996; 20(4):263-9. PubMed ID: 8818385
[TBL] [Abstract][Full Text] [Related]
26. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia.
Griesinger F; Hennig H; Hillmer F; Podleschny M; Steffens R; Pies A; Wörmann B; Haase D; Bohlander SK
Genes Chromosomes Cancer; 2005 Nov; 44(3):329-33. PubMed ID: 16001431
[TBL] [Abstract][Full Text] [Related]
27. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
[TBL] [Abstract][Full Text] [Related]
28. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
Kumar KR; Chen W; Koduru PR; Luu HS
Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
[TBL] [Abstract][Full Text] [Related]
29. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review.
Washburn E; Bayerl MG; Ketterling RP; Malysz J
Cancer Genet; 2021 Nov; 258-259():69-73. PubMed ID: 34551378
[TBL] [Abstract][Full Text] [Related]
30. Two alternatively spliced 5'BCR/3'JAK2 fusion transcripts in a myeloproliferative neoplasm with a three-way t(9;18;22)(p23;p11.3;q11.2) translocation.
Impera L; Lonoce A; Fanfulla DA; Moreilhon C; Legros L; Raynaud S; Storlazzi CT
Cancer Genet; 2011 Sep; 204(9):512-5. PubMed ID: 22018274
[TBL] [Abstract][Full Text] [Related]
31. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
Vizmanos JL; Hernández R; Vidal MJ; Larráyoz MJ; Odero MD; Marín J; Ardanaz MT; Calasanz MJ; Cross NC
Hematol J; 2004; 5(6):534-7. PubMed ID: 15570299
[TBL] [Abstract][Full Text] [Related]
32. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
Kim SY; Kim JE; Park S; Kim HK
Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
[TBL] [Abstract][Full Text] [Related]
33. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
35. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
Macdonald D; Reiter A; Cross NC
Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
[TBL] [Abstract][Full Text] [Related]
36. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
[TBL] [Abstract][Full Text] [Related]
37. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders.
Werner M; Nolte M; Kaloutsi V; Buhr T; Kausche F; Georgii A
Lab Invest; 1995 Apr; 72(4):405-10. PubMed ID: 7723278
[TBL] [Abstract][Full Text] [Related]
38. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia.
Cirmena G; Aliano S; Fugazza G; Bruzzone R; Garuti A; Bocciardi R; Bacigalupo A; Ravazzolo R; Ballestrero A; Sessarego M
Cancer Genet Cytogenet; 2008 Jun; 183(2):105-8. PubMed ID: 18503828
[TBL] [Abstract][Full Text] [Related]
39. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ
Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]